Argitalpenak (137) ROSA MARÍA RODRÍGUEZ FERNÁNDEZ argitalpenak

2024

  1. Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain

    Infectious Diseases and Therapy, Vol. 13, Núm. 6, pp. 1315-1331

  2. Long-term lung function follow-up of preterm infants less than 32 weeks of gestational age

    Pediatric Pulmonology, Vol. 59, Núm. 11, pp. 2922-2931

  3. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Clinical Relevance of RSV and SARS-CoV-2 Coinfections in Infants and Young Children

    Pediatric Infectious Disease Journal, Vol. 42, Núm. 12, pp. E473-E475

  2. Creation of a Pediatric Hospital Medicine Subspecialty in Spain

    Hospital Pediatrics

  3. How can we improve the quality of health care in hospital attendance of medically complex children?

    Andes Pediatrica, Vol. 94, Núm. 3, pp. 316-324

  4. Impact of the “daily huddle” on the safety of pediatric hospitalized patients

    Journal of Healthcare Quality Research, Vol. 38, Núm. 5, pp. 268-276

  5. Microbiota del tracto respiratorio

    Microbiota, probióticos y prebióticos: evidencia científica (Ergon), pp. 45-52

  6. Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

    The Lancet Global Health

  7. Respiratory Syncytial Virus Infection: Old Challenges and New Approaches

    Journal of Infectious Diseases, Vol. 228, Núm. 1, pp. 4-7

2022

  1. Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes

    Journal of Allergy and Clinical Immunology: Global, Vol. 1, Núm. 3, pp. 91-98

  2. Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic

    American Journal of Perinatology, Vol. 41, Núm. 4, pp. 515-521

  3. Do we overestimate intravenous fluid therapy needs? Adverse effects related to isotonic solutions during pediatric hospital admissions

    Nefrologia, Vol. 42, Núm. 6, pp. 688-695

  4. Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series

    Pediatric Infectious Disease Journal, Vol. 42, Núm. 1, pp. 1-7

2021

  1. Impact of an asthma education program during admission

    Hospital Pediatrics, Vol. 11, Núm. 8, pp. 849-855

  2. Longitudinal plasma cytokine concentrations and recurrent wheezing after RSV bronchiolitis

    Cytokine, Vol. 140

  3. Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection

    The Pediatric infectious disease journal, Vol. 40, Núm. 5, pp. S35-S39

  4. Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis

    Frontiers in Microbiology, Vol. 12

  5. Role of G2-S16 polyanionic carbosilane dendrimer in the prevention of respiratory syncytial virus infection in vitro and in vivo in mice

    Polymers, Vol. 13, Núm. 13

  6. The clinical relevance of the microbiome when managing paediatric infectious diseases—Narrative review

    Acta Paediatrica, International Journal of Paediatrics, Vol. 110, Núm. 2, pp. 441-449